This morning it could well be a good idea for investors to consider taking a look into the ViaDerma Inc (OTCMKTS:VDRM) stock in light of the announcement made by the company yesterday. The company announced yesterday that it was going to launch a new hair regrowth product which would be manufactured from Minoxidil.
Trading Data
On Wednesday, VDRM stock soared 4.96% to $0.0108 with more than 2.21 million shares, compared to its average volume of 3.94 million shares. The stock moved within a range of $0.0100 – 0.0127 after opening trade at $0.0109.
ViaDerma Announces Intent to Launch a New Minoxidil Hair Regrowth Product
It was announced that ViaDerma would integrate its own proprietary but patent pending carrier transdermal delivery technology with Minoxidil to develop the product. The company’s unique delivery technology would help with the help in transferring chemicals by way of the outermost layer of the skin and more importantly, it boasts of diffusion constant which was 10000 times higher than similar products in the market.
In addition to that, the hair regrowth market is fairly large and is expected to grow at and market studies by Grand View Research suggest that it would hit an eventual valuation of $13.6 billion by 2028. At this point Minoxidil is the main component in some of the highest selling hair regrowth products and when combined with the delivery system of ViaDerma, the product could prove to be a major earner for the company in the long run.
